Cargando…

The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases

INTRODUCTION: Thromboembolic events (TEs) are associated with considerable costs. However, there is a paucity of evidence quantifying the economic burden associated with TEs among patients with immune-mediated diseases (IMDs). METHODS: This retrospective cohort study used the IBM MarketScan(®) Comme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Setyawan, Juliana, Billmyer, Emma, Mu, Fan, Yarur, Andres, Zichlin, Miriam L., Yang, Hongbo, Downes, Nathaniel, Azimi, Nassir, Strand, Vibeke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799558/ https://www.ncbi.nlm.nih.gov/pubmed/34905149 http://dx.doi.org/10.1007/s12325-021-02004-1

Ejemplares similares

Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
por: Setyawan, Juliana, et al.
Publicado: (2021)

Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010–2019
por: Setyawan, Juliana, et al.
Publicado: (2021)

The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States
por: Woolley, Michael, et al.
Publicado: (2022)

P1738: A SEER-MEDICARE ANALYSIS OF THE ECONOMIC BURDEN AMONG ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH HYPOMETHYLATING AGENTS
por: McBride, A., et al.
Publicado: (2022)

Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis
por: Strand, Vibeke, et al.
Publicado: (2018)

The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with Schizophrenia
por: Zichlin, Miriam L., et al.
Publicado: (2021)

Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis
por: Rice, J. Bradford, et al.
Publicado: (2020)

Burden of Illness and Treatment Patterns Among Patients With von Willebrand Disease in US Clinical Practice
por: Swallow, Elyse, et al.
Publicado: (2023)

Patient Burden of Axial Spondyloarthritis
por: Strand, Vibeke, et al.
Publicado: (2017)

Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis
por: Pilon, Dominic, et al.
Publicado: (2019)

Correction: Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis
por: Pilon, Dominic, et al.
Publicado: (2021)

Effect of Comorbidity Burden on the Risk of Venous Thromboembolic Events After Total Knee Arthroplasty
por: Bala, Abiram, et al.
Publicado: (2021)

Economic Burden of Multiple Sclerosis Drugs in Iran during 2011–2019
por: Asadollahi, Mina, et al.
Publicado: (2023)

Demographics and economic burden of un-owned cats and dogs in the UK: results of a 2010 census
por: Stavisky, Jenny, et al.
Publicado: (2012)

Behind Recurrent Thromboembolic Events
por: Guerreiro, Sara, et al.
Publicado: (2016)

Thromboembolic events in polycythemia vera
por: Griesshammer, Martin, et al.
Publicado: (2019)

Thromboembolic events and Covid-19
por: Ribes, Agnès, et al.
Publicado: (2020)

Clozapine-Related Thromboembolic Events
por: Pallares Vela, Elisa, et al.
Publicado: (2021)

Economic burden of venous thromboembolism in surgical patients: A propensity score analysis from the national claims database in Vietnam
por: Bui, My Hanh, et al.
Publicado: (2020)

Incremental Health Care Resource Utilization and Economic Burden of Venous Thromboembolism Recurrence from a U.S. Payer Perspective
por: Lin, J., et al.
Publicado: (2014)

Risk assessment of thromboembolic events in hospitalized cancer patients
por: Nichetti, Federico, et al.
Publicado: (2021)

Burden of venous thromboembolism in patients with pancreatic cancer
por: Frere, Corinne
Publicado: (2021)

Inflammatory bowel disease and thromboembolic events: a c’lot to learn
por: Carvalho, Ana Catarina, et al.
Publicado: (2022)

Thromboembolic Events in a Socio-Economically Disadvantaged Population with COVID-19 Admitted to a Medicalized Hotel in Madrid
por: Ramírez-Cervantes, Karen Lizzette, et al.
Publicado: (2022)

A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy
por: Patel, Sanket, et al.
Publicado: (2023)

The Economic Burden of Cancers on Indian Households
por: Mahal, Ajay, et al.
Publicado: (2013)

Atrial Fibrillation and Cryptogenic Thromboembolic Events
por: Henz, Benhur Davi, et al.
Publicado: (2018)

Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK
por: Danese, Mark D, et al.
Publicado: (2016)

The Economic Burden of Dengue
por: Gubler, Duane J.
Publicado: (2012)

COVID-19-Associated Thromboembolic Events Causing Acute Mesenteric Ischaemia
por: Fan, Bingwen Eugene
Publicado: (2020)

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Thromboembolic events following brachytherapy: case reports
por: Guy, Jean-Baptiste, et al.
Publicado: (2015)

Thromboembolic Events in Patients with Inflammatory Bowel Disease
por: Algahtani, Farjah H., et al.
Publicado: (2016)

Venous thromboembolism events among RA patients
por: Mansour, Ribhi, et al.
Publicado: (2019)

Prevention of Thromboembolic Events in Patients with COVID-19
por: Warrior, Surbhi, et al.
Publicado: (2021)

Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US
por: Strand, Vibeke, et al.
Publicado: (2016)

863. Pre-Exposure Prophylaxis (PrEP) Prescriptions among Individuals at High Risk for HIV in the United States, 2012-2018
por: Zhou, Mo, et al.
Publicado: (2021)

Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease
por: Zulqarnain, Mir, et al.
Publicado: (2022)

Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases
por: Núñez, Paulina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a9sk6kqiucfpa6irr1sfb6a7vu